CVTX - CV Therapeutics, Inc. | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
CVTX - CV Therapeutics, Inc.

An SI Board Since January 1999

Posts	SubjectMarks	Bans
411	31	0

Emcee: Todd N. Weisrock	Type: Unmoderated

Introduction Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
136	down in the labs, they do strange and wonderful things...... J Lipid Res. 2003	scaram(o)uche	-	12/9/2003
135	well, down at this market cap and with oooooooodles of cash, it's worth the	scaram(o)uche	-	12/9/2003
134	You may be pleasantly surprised, but probably not all the way back to 26	tom pope	-	12/9/2003
133	<<Was going to buy a small - very small - amount today, but no trades, whi	quasi-geezer	-	12/9/2003
132	Very interesting "lifting the veil" type of post Rick, thanks. Was goi	tom pope	-	12/9/2003
131	A.J.: Glad you got the red flags you needed, and Miljenko was certainly bold in	scaram(o)uche	-	12/9/2003
130	<i> If the time between heart beats is extended too long, the result could	A.J. Mullen	-	12/9/2003
129	Now 1st Albany tells me??? Alas, where were they last week, when I could have s	mopgcw	-	12/8/2003
128	FDA May Require More Trials of CV Therapeutics' Ranexa Monday December 8, 1	mopgcw	-	12/8/2003
127	Stock is going to single digit, and this should happen three years ago, not toda	Miljenko Zuanic	-	12/8/2003
126	A little bit dated: <i>10:53 ET CV Therapeutics cut to Neutral at First A	tom pope	-	12/8/2003
125	CVTX down big premarket?	mopgcw	-	12/8/2003
124	Test message... please ignore	bornstei	-	12/5/2003
123	Kalypsys Enters Drug Discovery and Development Collaboration 2003-11-17 08:04 (N	mopgcw	-	11/17/2003
122	Jim, Rick and Peter explained well. Compound code name is BG9928. They called	Miljenko Zuanic	-	11/11/2003
121	My memory of Adentri is that the original formulation was IV only, and Biogen th	Biomaven	-	11/11/2003
120	You still have a good memory :-) 2001 10K report... In February 2000, Biogen	rkrw	-	11/11/2003
119	>> From CV's S1 9/25/1996!! << going out on a limb here......	scaram(o)uche	-	11/11/2003
118	In March 1997, CVT entered into two research collaboration and license agreement	rkrw	-	11/11/2003
117	Is this CVTX compound? Maybe they have different opinion on trial success, so t	Miljenko Zuanic	-	11/10/2003
116	>> "We are very pleased with the results of our Phase II trial of ora	scaram(o)uche	-	11/10/2003
115	latest on Adentri...... Message 19484708	scaram(o)uche	-	11/10/2003
114	Most likely. Also, imo, the main question is not “will or will not CVTX run new	Miljenko Zuanic	-	11/3/2003
113	<i>I thought an AC meeting was the norm.</i> Nope. Only have an AC	Biomaven	-	11/3/2003
112	Clearly there's a lot I don't know about the approval process. I though	A.J. Mullen	-	11/3/2003

Go to reply# or date (mm/dd/yy):